Sugi Predict

Sugi Predict / Compounds / SCHEMBL10116539

SCHEMBL10116539

SCHEMBL10116539

Cc1c(NC(=O)c2ccc(NS(=O)(=O)C(C)C)cc2)ccc2oc(=O)ccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP1LC3B Q9GZQ8 1/20 0.42
▸ MAP1LC3A Q9H492 1/20 0.42
▸ MAOB P27338 2/20 0.40
▸ MMP12 P39900 2/20 0.39
▸ MMP13 P45452 1/20 0.39
▸ NPC1 O15118 4/20 0.39
▸ RAB9A P51151 4/20 0.39
▸ POLB P06746 2/20 0.39
▸ CTDSP1 Q9GZU7 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ ALDH1A1 P00352 3/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ MAOA P21397 1/20 0.36
▸ ACHE P22303 1/20 0.36
▸ CA12 O43570 1/20 0.35
▸ CA1 P00915 1/20 0.35
▸ CA2 P00918 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10116253 0.85 MAOB (0.40) MAOBNPC1RAB9APOLBCTDSP1
SCHEMBL13565088 0.80 MAOB (0.39) MAOBMMP12MMP13MEN1KMT2A
SCHEMBL10116527 0.79 MEN1 (0.61) NPC1RAB9APOLBKDM4EALDH1A1
SCHEMBL13204916 0.76 KMT2A (0.51) NPC1RAB9AKDM4ELMNAALDH1A1
SCHEMBL10116538 0.74 MEN1 (0.57) NPC1RAB9APOLBKDM4EALDH1A1
SCHEMBL10116604 0.73 RAB9A (0.41) NPC1RAB9AKDM4ELMNAALDH1A1
SCHEMBL10116587 0.73 RAB9A (0.50) NPC1RAB9APOLBKDM4ELMNA
SCHEMBL10116551 0.73 RAB9A (0.50) NPC1RAB9AALDH1A1MEN1KMT2A
SCHEMBL10114789 0.72 ALDH1A1 (0.39) MAOBNPC1RAB9AKDM4ELMNA
SCHEMBL10116592 0.72 ALDH1A1 (0.44) NPC1RAB9AKDM4ELMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8115027-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2012-02-14 — — US disclosed
US-8115027-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2012-02-14 — — US disclosed
US-20110039802-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2011-02-17 — — US disclosed
US-20100292500-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2010-11-18 — — US disclosed
US-20100292500-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2010-11-18 — — US disclosed
US-7781461-B2 NPY Y5 antagonist KAWANISHI YASUYUKI 2010-08-24 — — US disclosed
US-7781461-B2 NPY Y5 antagonist KAWANISHI YASUYUKI 2010-08-24 — — US disclosed
US-7265130-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2007-09-04 — — US disclosed
US-7265130-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2007-09-04 — — US disclosed
US-20070015762-A1 NPY Y5 antagonist KAWANISHI YASUYUKI 2007-01-18 — — US disclosed
US-20070015762-A1 NPY Y5 antagonist KAWANISHI YASUYUKI 2007-01-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070015762-A1 NPY Y5 antagonist NPY5R, NPY1R, NPY2R MAP1LC3B 4212/4885MAP1LC3A 4146/4885MAOB 1153/4885
US-20100292500-A1 NPY Y5 ANTAGONIST NPY5R, NPY1R, NPY2R MAP1LC3B 3837/4885MAP1LC3A 3760/4885MAOB 1152/4885
US-20110039802-A1 NPY Y5 ANTAGONIST NPY5R, NPY1R, NPY2R MAP1LC3B 4245/4885MAP1LC3A 4188/4885MAOB 1144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.